Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies

被引:407
作者
Patel, Seema [1 ]
Rauf, Abdur [2 ]
Khan, Haroon [3 ]
Abu-Izneid, Tareq [4 ]
机构
[1] San Diego State Univ, Bioinformat & Med Informat Res Ctr, 5500 Campanile Dr, San Diego, CA 92182 USA
[2] Univ Swabi, Dept Chem, Anbar 23561, Khyber Pakhtunk, Pakistan
[3] Abdul Wali Khan Univ, Dept Pharm, Mardan 23200, Pakistan
[4] Umm Al Qura Univ, Dept Pharmaceut Chem, Fac Pharm, POB 42, Mecca, Saudi Arabia
关键词
Renin; Angiotensin II; Aldosterone; Vasopressin; Hypertension; I-CONVERTING-ENZYME; BLOOD-PRESSURE; MINERALOCORTICOID RECEPTOR; INSULIN-RESISTANCE; LIVER-DISEASE; SMOOTH-MUSCLE; HYPERTENSION; ESTROGEN; PREGNANCY; KIDNEY;
D O I
10.1016/j.biopha.2017.07.091
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Renin-angiotensin-aldosterone system (RAAS) is a vital system of human body, as it maintains plasma sodium concentration, arterial blood pressure and extracellular volume. Kidney-secreted renin enzyme acts on its substrate to form angiotensin II, a versatile effector peptide hormone. Every organ is affected by RAAS activation and the resultant hypertension, cell proliferation, inflammation, and fibrosis. The imbalance of renin and angiotensin II can result in an overwhelming number of chronic and acute diseases. RAAS is influenced by other enzymes, hormones, pumps and signaling pathways, hence, this review discusses important facets of this system, its crosstalk with other crucial factors like estrogen, thyroid, cortisol, kallikrein-kinin system, Wnt/b-catenin signaling, and sodium-potassium pump. The nexus of RAAS with the above-discussed systems was scantily explored before. So, this review furnishes a new perspective in comprehension of inflammation diseases. It is followed by the formulation of hypotheses, which can contribute to better management of an array of pathologies plaguing mankind. Manipulation of RAAS, by bending it towards ACE2 expression can regulate endocrine functions, which can be critical for a number of pathological management. Dietary intervention can restore RAAS to normalcy. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 140 条
[1]   The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases [J].
Abraham, Hazel Mae A. ;
White, C. Michael ;
White, William B. .
DRUG SAFETY, 2015, 38 (01) :33-54
[2]  
Aggarwal S, 2011, EXP CLIN CARDIOL, V16, P11
[3]   The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition [J].
Atlas, Steven A. .
JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (08) :S9-S20
[4]  
Baker P.R., 2012, CLIN ENDOCRINOL OXF, P76
[5]  
Barreto-Chaves M. L. M., 2017, VASCUL PHARM, P52
[6]   Microalbuminuria in Type 2 Diabetes and Hypertension A marker, treatment target, or innocent bystander? [J].
Basi, Seema ;
Fesler, Pierre ;
Mimran, Albert ;
Lewis, Julia B. .
DIABETES CARE, 2008, 31 :S194-S201
[7]   Angiotensin IIaldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase [J].
Batenburg, Wendy W. ;
Jansen, Pieter M. ;
van den Bogaerdt, Antoon J. ;
Danser, Alexander H. J. .
CARDIOVASCULAR RESEARCH, 2012, 94 (01) :136-143
[8]   Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy [J].
Batlle, Daniel ;
Wysocki, Jan ;
Soler, Maria J. ;
Ranganath, Keerthi .
KIDNEY INTERNATIONAL, 2012, 81 (06) :520-528
[9]   Angiotensin II signal transduction in vascular smooth muscle - Role of tyrosine kinases [J].
Berk, BC ;
Corson, MA .
CIRCULATION RESEARCH, 1997, 80 (05) :607-616
[10]   Angiotensin-converting enzyme overexpression in myelocytes enhances the immune response [J].
Bernstein, Kenneth E. ;
Gonzalez-Villalobos, Romer A. ;
Giani, Jorge F. ;
Shah, Kandarp ;
Bernstein, Ellen ;
Janjulia, Tea ;
Koronyo, Yosef ;
Shi, Peng D. ;
Koronyo-Hamaoui, Maya ;
Fuchs, Sebastien ;
Shen, Xiao Z. .
BIOLOGICAL CHEMISTRY, 2014, 395 (10) :1173-1178